Eyconis Announces Initiation of First-in-Human Clinical Trial of EYC-0305 in Treatment-Naïve Wet Age-Related Macular Degeneration Patients

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. TRMD
9. ACN
10. AZN

Go back to Eyconis Announces Initiation of First-in-Human Clinical Trial of EYC-0305 in Treatment-Naïve Wet Age-Related Macular Degeneration Patients
Asianada, Inc. (NASDAQ: ASND) Delayed: 236.72 -2.32 (0.97%)
Previous Close $239.04    52 Week High $21.79 
Open $238.15    52 Week Low $11.92 
Day High $243.68    P/E N/A 
Day Low $236.02    EPS $-0.07 
Volume 1,558,774